// App-Quantinova.ai

BSH2020‐OR‐040 : A novel assay of neutrophil extracellular traps (NETs) formation independently predicts DIC and identifies the rationale for anti‐IL‐8 therapies

Researchers

Presenter

  • S. Abrams

Principal Investigators

  • B. Morton

  • Y. Alhamdi

  • M. Alsabani

  • Z. Cheng

  • S. Lane

  • I. welters

  • G. Wang

  • C.-H. Toh

Medical Centers

  • Institute of Infection and Global Health, University of Liverpool, Liverpool,United Kingdom

  • Cambridge University Hospitals NHS Foundation Trust

  • Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK

  • The Medical School, Southeast University, Nanjing, China

  • Institute of Translational Medicine

  • MRC/ARUK Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom

  • Intensive Care Unit, H

  • The Roald Dahl Haemostasis and Thrombosis Centre,Royal Liverpool University Hospital,Liverpool,United Kingdom

Locations

  • United Kingdom

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

Disease

  • Disseminated intravascular coagulation

  • Sepsis

Biomarkers

  • Alanine transaminase

  • Cytokine

Drug/Treatment

  • Interleukin

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved